Clear Creek Financial Management’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Clear Creek Financial Management’s Portfolio NBRV Stock Details NBRV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-554	Closed	-$8K	–	381
2021 Q4	$8K	Sell	554 -220	-28%	-$5.21K	﹤0.01%	353
2021 Q3	$23K	Sell	774 -28	-3%	-$790	﹤0.01%	322
2021 Q2	$27K	Buy	+802	New	+$29.9K	﹤0.01%	331
2021 Q1	–	Sell	-802	Closed	-$48K	–	295
2020 Q4	$48K	Buy	+802	New	+$86.9K	0.01%	296
2020 Q3	–	Sell	-1,160	Closed	-$195K	–	285
2020 Q2	$195K	Buy	1,160 +712	+159%	+$119K	0.05%	225
2020 Q1	$62K	Hold	448	–	–	0.02%	165
2019 Q4	$157K	Buy	448 +236	+111%	+$108K	0.06%	134
2019 Q3	$108K	Buy	+212	New	+$120K	0.05%	129

Other funds holding NBRV

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

AICPI

ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

VFA

Values First Advisors Gray, Tennessee $219M AUM 33.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Clear Creek Financial Management's NBRV Position: Q1 2022 in Review

Clear Creek Financial Management sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q1 2022, closing a stake of 554 shares — an estimated $8K sold.

Clear Creek Financial Management first reported a position in NBRV in Q3 2019 and held it in 8 quarters. The position peaked at $195K in Q2 2020. 29 funds tracked by Wall St. Rank hold NBRV as of Q1 2022.

Clear Creek Financial Management reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q1 2022 after selling out during the quarter.
Clear Creek Financial Management sold 554 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q1 2022, an estimated $8K.
Clear Creek Financial Management first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q3 2019 and held it in 8 quarters.
Clear Creek Financial Management's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $195K in Q2 2020.
29 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q1 2022.

Based on Clear Creek Financial Management's 13F filing for Q1 2022, filed 2 May 2022.